China Center for Pharmaceutical Research and Development

The China Center for Pharmaceutical Research and Development (CCPRD) is a premier research and development institution based in Beijing, China, and is a key component of the Peking University Health Science Center. Founded to bridge the gap between academic research and industrial application, the center specializes in the innovation of novel drug delivery systems (NDDS), including liposomes, microspheres, and nanotechnology-based platforms. CCPRD operates as a high-level contract research organization (CRO) and a national engineering center, providing comprehensive services in formulation development, pharmacokinetics, and bioequivalence studies to both domestic and international pharmaceutical companies. The center is notably recognized for its contribution to the development of advanced formulations, such as the paclitaxel liposome product Lipusu, and its leadership in national pharmaceutical research initiatives. Through its extensive academic and industrial collaborations, CCPRD continues to drive the technical evolution of the Chinese healthcare sector, focusing on improving the efficacy and safety of therapeutic agents across multiple disease areas.